Market map: Meet the companies deploying AI agents in the outpatient setting
First, a disclaimer: No market map is fully exhaustive.
We focused our efforts on the companies deploying AI agents in the ambulatory or outpatient setting. These companies are generally also post-series A, as there has been an explosion of pre-seed and seed activity in the space. We also excluded vendors whose primary business model is selling into healthcare systems. Submissions came from a cross section of our network, inclusive of venture capital investors, operators, and founders (see the full list that contributed directly underneath the map).
To be fully transparent, we struggled a bit in the scribe category because, in some cases, the agents involve a roadmapping exercise, while others are live.
If your company fits the criteria and should be on the list, reach out to us before our next update!
|
Reserve Your Spot for Upcoming Webinars!
Webinar Topic | Panelists’ | Timing | Registration |
|---|---|---|---|
Privacy AI and the future of HIPAA with the former founding director of ONC | Jodi Daniel, Christina Farr | June 3rd, 2026 | |
Not everyone can access the Top 1% of physicians. Will AI change that? | Daniel Stein | June 23rd, 2026 |
Want to support Second Opinion?
- 🌟 Leave a review for the Second Opinion Podcast
- 📧 Share this email with other friends in the healthcare space!
- 💵 Become a paid subscriber!
- 📢 Become a sponsor